Thursday, July 31, 2025 |
|
Revenue of LEQEMBI(R) (Preliminary Basis)
17:27 HKT/SGT
|
|
|
Shoucheng Buys Back 20M Shares in 2 Days, Signals Strong Bet
16:40 HKT/SGT
|
|
|
連回超2000萬股 首程控股真金白銀釋放低估訊號
16:40 HKT/SGT
|
|
|
连回超2000万股 首程控股用真金白银传递坚定信号
16:40 HKT/SGT
|
|
|
Transfer of Sharp Mie Plant No.2 and part of the land at Mie Base
16:11 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL GROUP Announces Business Partnership with JEPLAN to Realize a Decarbonized, Circular Society
14:00 HKT/SGT
|
|
|
三菱重工、開発中の無人機による災害発生時の救援物資輸送を実証
12:30 HKT/SGT
|
|
|
金嗓子:喉寶產品獲烏茲別克斯坦衛生部認證
11:10 HKT/SGT
|
|
|
金嗓子:喉宝产品获乌兹别克斯坦卫生部认证
11:10 HKT/SGT
|
|
|
Champion REIT Hosts ESG-Themed Event for a Third Year, Redefining Value and Sustainable Future of Commercial Properties Through Innovation
10:56 HKT/SGT
|
|
|
DENSO Announces First Quarter Financial Results
10:25 HKT/SGT
|
|
|
Honda Launches All-New Prelude Teaser Page Ahead of Scheduled September 2025 Market Introduction
10:20 HKT/SGT
|
|
|
MHI Demonstrates Transport of Relief Supplies in the Event of a Disaster Using Uncrewed Aerial Vehicles Currently in Development
10:00 HKT/SGT
|
|
|
Over 20 Million Shares Repurchased in Two Days, Shoucheng Holdings Sends a Strong Signal with Decisive Action
09:00 HKT/SGT
|
|
|
連續回購逾2000萬股 首程控股率先出手釋放強烈信號
09:00 HKT/SGT
|
|
|
连续回购超2000万股 首程控股率先出手释出强信号
09:00 HKT/SGT
|
|
|
Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
08:30 HKT/SGT
|
|
|
New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
08:20 HKT/SGT
|
|
|
Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
08:10 HKT/SGT
|
|
|
Wednesday, July 30, 2025 |
|
HKTDC welcomes the 'Report on Hong Kong's Business Environment' and continues to actively promote Hong Kong's advantages
22:40 HKT/SGT
|
|
|
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
21:41 HKT/SGT
|
|
|
New Report Reveals Key Considerations For Successful Distribution Onboarding
21:00 HKT/SGT
|
|
|
Hong Kong Shopping Festival Returns in August with Bigger and Better 2nd Edition
19:29 HKT/SGT
|
|
|
冠君產業信託三度舉辦ESG主題盛會 創新定義商廈價值與可持續未來
18:00 HKT/SGT
|
|
|
冠君产业信托三度举办ESG主题盛会 创新定义商厦价值与可持续未来
18:00 HKT/SGT
|
|
|
Production, Sales and Export Results for June, 2025
17:24 HKT/SGT
|
|
|
Sales, Production, and Export Results for the First Half of 2025
17:06 HKT/SGT
|
|
|
かんぽ生命、KKR及びGlobal Atlantic運用の再保険ビークルへ20億米ドルを投資
15:30 HKT/SGT
|
|
|
Honda、2025年6月度 四輪車 生産・販売・輸出実績を発表
15:10 HKT/SGT
|
|
|
トヨタ、2025年上半期 販売・生産・輸出実績を発表
13:30 HKT/SGT
|
|
|
Ongoing Share Buybacks Demonstrate Confidence, Shoucheng Holdings Boosts Market Expectations with Concrete Action
11:00 HKT/SGT
|
|
|
持續回購顯信心 首程控股以實際行動提振市場預期
11:00 HKT/SGT
|
|
|
持续回购显信心 首程控股以实际行动提振市场预期
11:00 HKT/SGT
|
|
|
Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB
10:00 HKT/SGT
|
|
|
Tuesday, July 29, 2025 |
|
Naoris Protocol Announces Upcoming TGE for $NAORIS
23:59 HKT/SGT
|
|
|
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
19:00 HKT/SGT
|
|
|
Wintermar Offshore (WINS:JK) Reports 1H2025 Results
18:56 HKT/SGT
|
|
|
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
16:00 HKT/SGT
|
|
|
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
13:30 HKT/SGT
|
|
|
GTJAI Achieved 'Carbon Neutrality' at Operational Level for the Third Consecutive Year
13:15 HKT/SGT
|
|
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
11:30 HKT/SGT
|
|
|
宇樹衝刺IPO、機械人應用加速落地:首程控股雙輪驅動兌現紅利
11:30 HKT/SGT
|
|
|
宇树冲刺IPO、机器人应用加速落地:首程控股双轮驱动兑现红利
11:30 HKT/SGT
|
|
|
國泰君安國際連續第三年實現營運層面「碳中和」
11:19 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
08:01 HKT/SGT
|
|
|
|
|